These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24693444)

  • 1. Evaluation of the Oncogenic Human Papillomavirus DNA Test with Liquid-Based Cytology in Primary Cervical Cancer Screening and the Importance of the ASC/SIL Ratio: A Belgian Study.
    Catteau X; Simon P; Noël JC
    ISRN Obstet Gynecol; 2014; 2014():536495. PubMed ID: 24693444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women.
    Donders GG; Depuydt CE; Bogers JP; Vereecken AJ
    PLoS One; 2013; 8(12):e86266. PubMed ID: 24386492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-based screening for cervical cancer among women 55-59 years of age.
    Bergengren L; Lillsunde-Larsson G; Helenius G; Karlsson MG
    PLoS One; 2019; 14(6):e0217108. PubMed ID: 31199811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid-Based Cervical Cytology: Monitoring the Laboratory Quality Indicators.
    Nayak SS; Dutta A; Khedkar R; Roy S
    J Cytol; 2024; 41(1):1-7. PubMed ID: 38282808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature.
    Shidham VB; Kumar N; Narayan R; Brotzman GL
    Cytojournal; 2007 Mar; 4():7. PubMed ID: 17374161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
    Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
    Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cdk inhibitors p16, p21cip1, p27kip1, and cyclin E in cervical cytological smears prepared by the ThinPrep method.
    Moore GD; Lear SC; Wills-Frank LA; Martin AW; Snyder JW; Helm CW
    Diagn Cytopathol; 2005 Feb; 32(2):82-7. PubMed ID: 15637682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion triage in Korean women: Revisiting the 2012 American Society of Colposcopy and Cervical Pathology screening guidelines.
    Hyun JY; Min KJ; Yang SY; Lee JK; Hong JH
    Obstet Gynecol Sci; 2017 Jul; 60(4):357-361. PubMed ID: 28791267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of human papillomavirus infection determined by hybrid capture assay in cervical lesions in a Venezuelan population.
    Correnti M; Cavazza ME; Herrera O; Rodríguez A
    Invest Clin; 2010 Mar; 51(1):27-35. PubMed ID: 20815154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hrHPV positivity in ASC-US Papanicolaou tests from women with treated HPV- and non-HPV-related gynecologic malignancies.
    Paintal A; Heagley D
    J Am Soc Cytopathol; 2016; 5(4):216-220. PubMed ID: 31042511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16INK4a as an adjunct marker in liquid-based cervical cytology.
    Sahebali S; Depuydt CE; Segers K; Moeneclaey LM; Vereecken AJ; Van Marck E; Bogers JJ
    Int J Cancer; 2004 Mar; 108(6):871-6. PubMed ID: 14712490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytohistological discrepancies of cervico-vaginal smears and HPV status.
    Alanbay İ; Öztürk M; Fıratlıgil FB; Karaşahin KE; Yenen MC; Bodur S
    Ginekol Pol; 2017; 88(5):235-238. PubMed ID: 28580567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-specific Distribution of Cervical hrHPV Infection and the Association with Cytological and Histological Results in a Large Population-based Cervical Cancer Screening Program: Baseline and 3-year Longitudinal Data.
    Song F; Du H; Xiao A; Wang C; Huang X; Liu Z; Zhao M; Men H; Wu R
    J Cancer; 2020; 11(20):6157-6167. PubMed ID: 32922555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.